http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0059182-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N11-087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-04
filingDate 1981-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1984-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1984-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0059182-B1
titleOfInvention A process for isolating aminoacylase enzyme from a mammal kidney extract
abstract An improved method for the isolation of aminoacylase enzyme from mammal kidneys. According to the invention an aqueous kidney extract, prepared in a manner known per se, is subjected to heat treatment at 60 to 80`C for 5 to 15 minutes, the heat treated mixture is centrifuged, 200 to 300 g/litre of a salt of the general formula K<ux>uA (wherein K stands for a monovalent cation, A is the anion of a mineral acid and x is equal to the valence of the anion) are added to the supernatant, the resulting suspension is centrifuged, the separated precipitate is dissolved in water, the solution is dialyzed against water, and, if desired, the dialyzed solution or a solution of the enzyme, separated from the dialyzate, in a buffer of pH 6.5 to 8.5 is subjected to anion exchange chromatography, finally, if desired, the active fractions obtained in the chromatographic step or a solution of the enzyme, precipitated from the active fractions with a salt of the general formula KxA, in a buffer of pH 6.0 to 8.0 is subjected to gel chromatography on a gel filter wherein the upper limit of the fractionation molecular weight is higher than 70,000, and the enzyme is precipitated from the active fractions with a salt of the general formula K<ux>uA as described above. The invention also relates to an immobilized aminoacylase enzyme consisting of a partially hydrolyzed A krilex P type acrylamide-N,N'-methylene-bis(acrylamide) copolymer and an aminoacylase enzyme attached to said copolymer by covalent bonds This immobilized enzyme preparation is prepared according to the invention so that a partially hydrolyzed Akrilex P type copolymer is treated with a carbodiimide compound which is soluble in water or soluble in an organic solvent at a temperature below 0`C, a solution of the aminoacylase with a pH of 6.5 to 8.5 is applied onto the resulting activated support, the resulting product is washed and then dried, if desired. By the improved method of the invention aminoacylase can be separated from mammal kidneys far more easily than before. The immobilized enzyme preparations according to the invention are of extremely high specific activity.
priorityDate 1980-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2769749-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1289549-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6DG85
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448580
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO44111
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11645
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP25689
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23194
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD8JBB7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54LT2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP34798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8MKJ2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP25688
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8MHW6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8MKJ3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453962614
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33282
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ00511
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO04104
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP78609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54338471
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO04420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490886
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP82858
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO74409
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP34799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4GPU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22673
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09118
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP53763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232006114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226483379
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5FZI9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227248009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22921
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16164
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD0VWQ1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3MHG7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04670

Total number of triples: 63.